One Size Doesn’t Fit All: Why CRO Flexibility Matters More Than Ever

In today’s clinical development landscape, no two trials, or trial Sponsors, are exactly alike. Each organization brings its own needs, priorities, and operating models to the table. For this reason, outsourcing strategies for clinical trials can vary widely. Some Sponsors prefer to engage multiple specialized vendors, selecting only the services they need to complement their internal capabilities. Others opt for a single, full-service CRO to manage the entire trial, leaning on a unified partner for seamless execution.

By |2025-04-16T22:07:52+01:00March 25th, 2025|WEP Insights|

Early Access Programs (EAPs) in France: A Strategic Advantage for Pharma and Biotech Companies

Early Access Programs (EAPs) in France provide pharmaceutical and biotech companies with a valuable opportunity to offer patients innovative treatments before obtaining formal marketing authorization. Regulated by the French National Agency for the Safety of [...]

By |2025-03-06T16:44:24+00:00March 6th, 2025|Uncategorised|